Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Shares Outstanding (2022 - 2025)

CervoMed's Shares Outstanding history spans 8 years, with the latest figure at $9.3 million for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 12.1% year-over-year to $9.3 million; the TTM value through Sep 2025 reached $9.3 million, up 12.1%, while the annual FY2024 figure was $8.7 million, 53.36% up from the prior year.
  • Shares Outstanding for Q3 2025 was $9.3 million at CervoMed, roughly flat from $9.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $45.6 million in Q3 2024 and bottomed at $10000.0 in Q1 2022.
  • The 4-year median for Shares Outstanding is $5.9 million (2023), against an average of $7.6 million.
  • The largest annual shift saw Shares Outstanding skyrocketed 33212.01% in 2023 before it plummeted 81.49% in 2025.
  • A 4-year view of Shares Outstanding shows it stood at $518140.0 in 2022, then skyrocketed by 995.17% to $5.7 million in 2023, then surged by 53.36% to $8.7 million in 2024, then rose by 6.32% to $9.3 million in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Shares Outstanding are $9.3 million (Q3 2025), $9.3 million (Q2 2025), and $8.7 million (Q1 2025).